RI

Robert W. Georgantas, III

ML Medimmune Limited: 3 patents #250 of 738Top 35%
AM Amgen: 2 patents #1,289 of 2,867Top 45%
BI Biodesix: 2 patents #16 of 32Top 50%
The Johns Hopkins University: 1 patents #1,892 of 4,416Top 45%
📍 Gaithersburg, MD: #308 of 1,746 inventorsTop 20%
🗺 Maryland: #5,505 of 35,612 inventorsTop 20%
Overall (All Time): #791,898 of 4,157,543Top 20%
6
Patents All Time

Issued Patents All Time

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
11894147 Method for predicting risk of unfavorable outcomes, e.g., in COVID-19 hospitalization, from clinical characteristics and basic laboratory findings Thomas A. Campbell, Heinrich Röder, Joanna Röder, Laura Maguire 2024-02-06
11476003 Method for predicting risk of unfavorable outcomes, e.g., in COVID-19 hospitalization, from clinical characteristics and basic laboratory findings Thomas A. Campbell, Heinrich Röder, Joanna Röder, Laura Maguire 2022-10-18
11220541 CCL20 as a predictor of clinical response to IL23-antagonists Chris Morehouse, Brandon Higgs, Koustubh Ranade, Katie Streicher, William Rees +7 more 2022-01-11
11016099 Prediction of clinical response to IL23-antagonists using IL23 pathway biomarkers Chris Morehouse, Brandon Higgs, Koustubh Ranade, Katie Streicher, William Rees +7 more 2021-05-25
10006026 Recombinant polypeptide production Katie Streicher, Jonathan P. Jacobs, Lydia Greenlees, Koustubh Ranade, Michael Bowen 2018-06-26
7799528 Therapeutic and diagnostic applications of genes differentially expressed in lympho-hematopoietic stem cells Curt I. Civin 2010-09-21